E-viri
Recenzirano
Odprti dostop
-
Bajrangee, A.; Coughlan, J.J.; Teehan, S.; O'Connor, C.; Murphy, R.T.; Foley, B.; Daly, C.; Burke, D.; Maree, A.O.; Crean, P.A.
International journal of cardiology. Heart & vasculature, 09/2017, Letnik: 16, Številka: CJournal Article
TAVI is a percutaneous approach to aortic valve replacement in high surgical risk patients deemed inoperable. To evaluate the early and mid-term outcomes for an Irish TAVI cohort over a six-year period at St James's Hospital and Blackrock Clinic, Dublin, Ireland. In total 147 patients, 56% male with an average age of 82 underwent TAVI between December 2008 and December 2014. Thirty day, one year and two year survival was 90.5%, 83% and 71% respectively. Major vascular complications and renal failure were the biggest predictors of mortality at 30days (p=0.02). We observed a pacing rate of 13.5%, the majority in patients who had Medtronic Corevalve implants (p<0.05). With increasing procedural experience there was a reduction in length of stay from 10days to 7.5days. This review, the first of its kind in Ireland showed favorable rates of 30day and one year and two year survival post TAVI with procedural success and complication rates similar to international registry data.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.